Related Experiment Videos
Hepatic resection for large hepatocellular carcinoma
K Hanazaki1, S Kajikawa, N Shimozawa
1Second Department of Surgery, Shinshu University School of Medicine, 3-1-1 Asahi, 390-8621, Matsumoto, Japan. hanayan@hsp.md.shinshu-u.ac.jp
American Journal of Surgery
|July 5, 2001
Summary
Long-term survival after liver resection for large hepatocellular carcinoma (HCC) is poor. Minimizing intraoperative blood transfusions may improve outcomes for patients with large HCC.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Hepatocellular Carcinoma Research
Background:
- Long-term survival and prognostic factors for large hepatocellular carcinoma (HCC) after hepatic resection require further investigation.
- Hepatocellular carcinoma (HCC) is a significant global health concern, with large tumors posing unique surgical challenges.
Purpose of the Study:
- To evaluate the surgical outcomes and identify prognostic factors in patients undergoing hepatic resection for large HCC (>= 5 cm).
- To compare the survival rates of patients with large HCC versus small HCC after surgical resection.
Main Methods:
- Retrospective analysis of 133 patients with large HCC (L group) and 253 patients with small HCC (S group) who underwent hepatic resection.
- Univariate and multivariate analyses using Cox's proportional hazards model were employed to identify prognostic factors.
Main Results:
- Disease-free survival rates at 3 and 5 years were significantly lower in the large HCC group (26% vs 42% and 20% vs 25%, respectively).
- Overall survival rates at 3 and 5 years were also significantly lower in the large HCC group (38% vs 67% and 28% vs 47%, respectively).
- Multivariate analysis identified a large volume of intraoperative blood transfusion as an independent predictor of poor disease-free and overall survival.
Conclusions:
- Long-term survival for patients with large HCC following hepatic resection is unsatisfactory compared to those with smaller tumors.
- Reducing intraoperative blood transfusions may be crucial for improving survival and reducing recurrence rates in patients with large HCC.